Clinical Trial: PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07884877) titled 'PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer' on Oct. 13.

Brief Summary: The goal of this clinical trial is to learn if adding PULSAR, a personalized adaptive stereotactic radiotherapy, to standard immunotherapy can control cancer longer in adults with high-risk advanced hepatocellular carcinoma (liver cancer). It will also learn about the safety of this combination. The main questions it aims to answer are:

* What percentage of participants are alive without cancer progression 12 months after starting PULSAR?

* What medical problems do participants have after PULSAR with immunotherapy?

Ther...